BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 21342129)

  • 1. Pathobiology and prevention of cancer chemotherapy-induced bone growth arrest, bone loss, and osteonecrosis.
    Fan C; Foster BK; Wallace WH; Xian CJ
    Curr Mol Med; 2011 Mar; 11(2):140-51. PubMed ID: 21342129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children.
    Fan C; Georgiou KR; King TJ; Xian CJ
    J Biomed Biotechnol; 2011; 2011():903097. PubMed ID: 21541196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical activity in the prevention and amelioration of osteoporosis in women : interaction of mechanical, hormonal and dietary factors.
    Borer KT
    Sports Med; 2005; 35(9):779-830. PubMed ID: 16138787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chemotherapy on bone metabolism and skeletal growth.
    Siebler T; Shalet SM; Robson H
    Horm Res; 2002; 58 Suppl 1():80-5. PubMed ID: 12373019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of genistein aglycone on the development of osteonecrosis of the femoral head and secondary osteoporosis induced by methylprednisolone in rats.
    Bitto A; Polito F; Burnett B; Levy R; Di Stefano V; Armbruster MA; Marini H; Minutoli L; Altavilla D; Squadrito F
    J Endocrinol; 2009 Jun; 201(3):321-8. PubMed ID: 19332450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The roles of exercise in bone remodeling and in prevention and treatment of osteoporosis.
    Yuan Y; Chen X; Zhang L; Wu J; Guo J; Zou D; Chen B; Sun Z; Shen C; Zou J
    Prog Biophys Mol Biol; 2016 Nov; 122(2):122-130. PubMed ID: 26657214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone therapy/adjuvant chemotherapy induced deleterious effects on the bone mass of breast cancer patients and the intervention of physiotherapy: a literature review.
    Tonezzer T; Pereira CM; Filho UP; Marx A
    Eur J Gynaecol Oncol; 2010; 31(3):262-7. PubMed ID: 21077466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
    Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
    Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocorticoid-induced osteoporosis: an update.
    Compston J
    Endocrine; 2018 Jul; 61(1):7-16. PubMed ID: 29691807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Resveratrol Supplementation on  Methotrexate Chemotherapy-Induced Bone Loss.
    Lee AM; Shandala T; Soo PP; Su YW; King TJ; Chen KM; Howe PR; Xian CJ
    Nutrients; 2017 Mar; 9(3):. PubMed ID: 28282956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug-induced osteopathies. Drugs, pathogenesis, forms, diagnosis, prevention and therapy].
    Bartl R; Bartl C; Gradinger R
    Z Rheumatol; 2010 Mar; 69(2):135-50; quiz 151. PubMed ID: 20146045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decade of bisphosphonate bone complications: what it has taught us about bone physiology.
    Marx RE
    Int J Oral Maxillofac Implants; 2014; 29(2):e247-58. PubMed ID: 24683588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper.
    Migliorati CA; Casiglia J; Epstein J; Jacobsen PL; Siegel MA; Woo SB
    J Am Dent Assoc; 2005 Dec; 136(12):1658-68. PubMed ID: 16383047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone loss and fracture risk associated with cancer therapy.
    Guise TA
    Oncologist; 2006; 11(10):1121-31. PubMed ID: 17110632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.
    Marx RE; Sawatari Y; Fortin M; Broumand V
    J Oral Maxillofac Surg; 2005 Nov; 63(11):1567-75. PubMed ID: 16243172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoid-induced osteoporosis: mechanisms for bone loss; evaluation of strategies for prevention.
    Mitchell DR; Lyles KW
    J Gerontol; 1990 Sep; 45(5):M153-8. PubMed ID: 2203846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis.
    Zalavras C; Shah S; Birnbaum MJ; Frenkel B
    Crit Rev Eukaryot Gene Expr; 2003; 13(2-4):221-35. PubMed ID: 14696969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Musculoskeletal Effects of Cancer and Cancer Treatment.
    Wustrack R; Rao SS; Morris CD
    J Am Acad Orthop Surg; 2020 Aug; 28(16):e716-e728. PubMed ID: 32769720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folinic acid attenuates methotrexate chemotherapy-induced damages on bone growth mechanisms and pools of bone marrow stromal cells.
    Xian CJ; Cool JC; Scherer MA; Fan C; Foster BK
    J Cell Physiol; 2008 Mar; 214(3):777-85. PubMed ID: 17786974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of chemotherapy on the growing skeleton.
    van Leeuwen BL; Kamps WA; Jansen HW; Hoekstra HJ
    Cancer Treat Rev; 2000 Oct; 26(5):363-76. PubMed ID: 11006137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.